日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer

接受帕博利珠单抗治疗的非小细胞肺癌患者的免疫相关不良事件、全身炎症生物标志物和生存结局

Raynes, George; Stares, Mark; Low, Samantha; Haron, Dhania; Sarwar, Hussain; Abhi, Dhruv; Barrie, Colin; Laird, Barry; Caledonian Cachexia Collaborative; Phillips, Iain; MacKean, Melanie